Scarica l'app Stockscreener
29.07
2.68%
0.76
Pre-mercato:
28.96
-0.11
-0.38%
Atricure Inc Borsa (ATRC) Ultime notizie
Should AtriCure’s Q4 Revenue Beat and Cautious Analyst Tone Reshape the ATRC Investment Narrative? - Sahm
AtriCure (NASDAQ:ATRC) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ATRC Should I Buy - Intellectia AI
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Freedom Capital - MarketBeat
Freedom Capital Markets initiates Articure stock with buy rating By Investing.com - Investing.com South Africa
Freedom Capital Markets initiates Articure stock with buy rating - investing.com
ATRC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Valuation Update: What are AtriCure Incs recent SEC filings showingQuarterly Market Review & Stock Market Timing Techniques - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
AtriCure stock hits 52-week low at $28.25 amid market fluctuations - Investing.com Australia
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart - Capital.com
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Resistance Check: Whats the fair value of AtriCure Inc stock2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
AtriCure Shares Plunge to New 1-Year Low - National Today
AtriCure (NASDAQ:ATRC) Hits New 1-Year LowHere's Why - MarketBeat
Risk Check: Is AtriCure Inc a top pick in the sector2026 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn
Technical Reactions to ATRC Trends in Macro Strategies - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Projecting the Global Cardiac Ablation Devices Market Size to Expand at a 13.25% CAGR Through 2032, DelveInsight Analysis - Barchart
Vanguard disaggregates holdings; AtriCure (NASDAQ: ATRC) shows 0 shares - Stock Titan
Market Outlook: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARTake Profit & Safe Capital Investment Plans - baoquankhu1.vn
Trend Report: Is AtriCure Inc in accumulation or distribution phase2026 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amidst Market Challenges - Markets Mojo
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? - AOL.com
MACD Signal: Should value investors consider AtriCure Inc2026 Retail Activity & Weekly High Return Forecasts - baoquankhu1.vn
DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox
ATRC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Market Wrap: Is now the right time to enter AtriCure IncPortfolio Return Report & Accurate Intraday Trading Signals - baoquankhu1.vn
AtriCure Chief Scientific Officer Stock SaleMarch 2026 Transaction DetailsNews and Statistics - IndexBox
AtriCure unveils case-based training to build Afib program skills - Traders Union
AtriCure Stock Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Aug Patterns: Is AtriCure Inc undervalued by DCF analysisMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn
Growth Value: Is AtriCure Inc stock trending bullish2026 Selloffs & Real-Time Stock Movement Alerts - baoquankhu1.vn
Ablation Devices Market to Reach USD 15.34 Billion by 2034, Growing at a CAGR of 8.38% Driven by Rising Chronic Disease Burden and Advancements in Minimally Invasive Technologies | DelveInsight - Barchart
Investor Mood: Should I hold or sell ABRPRF now2026 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Trading the Move, Not the Narrative: (ATRC) Edition - Stock Traders Daily
Insider Sell: Vinayak Doraiswamy Sells 5,000 Shares of AtriCure Inc (ATRC) - GuruFocus
Growth Value: Why is AtriCure Inc stock going downIndex Update & Growth Focused Investment Plans - baoquankhu1.vn
AtriCure (NASDAQ:ATRC) Insider Vinayak Doraiswamy Sells 5,000 Shares - MarketBeat
AtriCure CSO Doraiswamy sells $149k in stock - Investing.com Nigeria
AtriCure CSO Doraiswamy sells $149k in stock By Investing.com - Investing.com Australia
AtriCure (ATRC) Chief Scientific Officer sells 5,000 shares at $29.83 - Stock Titan
First Light Asset Management LLC Sells 124,808 Shares of AtriCure, Inc. $ATRC - MarketBeat
Kennedy Capital Management LLC Boosts Stock Holdings in AtriCure, Inc. $ATRC - MarketBeat
ATRC (NASDAQ: ATRC) files Form 144 reporting proposed sale of award shares - Stock Titan
Director at AtriCure (NASDAQ: ATRC) exercises 10,000 stock options - Stock Titan
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI) - The Globe and Mail
AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates - Yahoo Finance
AtriCure at The Citizens Life Sciences Conference: Strategic Growth Outlook By Investing.com - Investing.com Canada
ATRC Technical Analysis & ETF Price Forecast - Intellectia AI
AtriCure (ATRC) CEO reports family stock gifts in Form 4 - Stock Titan
Citigroup Inc. Purchases 36,839 Shares of AtriCure, Inc. $ATRC - MarketBeat
Moving Averages: Does AtriCure Inc have declining or rising EPS2026 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):